Journal
DISEASE MODELS & MECHANISMS
Volume 2, Issue 3-4, Pages 189-195Publisher
COMPANY BIOLOGISTS LTD
DOI: 10.1242/dmm.002113
Keywords
-
Categories
Funding
- Miriam and Sheldon Adelson Program in Neural Repair Research
- David Vickter Foundation
- NIH/NINDS [K08 N5002240]
- UCLA Department of Molecular and Medical Pharmacology
Ask authors/readers for more resources
Human embryonic stem cell (hESC)-derived neurons have the potential to model neurodegenerative disorders. Here, we demonstrate the expression of a mutant gene, superoxide dismutase 1 (SOD 1), 1 inked to familial amyotrophic lateral sclerosis (ALS) in hESC-derived motor neurons. Green fluorescent protein (GFP) expression under the control of the HB9 enhancer was used to identify SOD1-transfected motor neurons that express human wildtype SOD1 or one of three different mutants (G93A, A4V and I113T) of SOD I. Neurons transfected with mutant SOD I exhibited reduced cell survival and shortened axonal processes as compared with control-transfected cells, which could survive for 3 weeks or more. The results indicate that hESC-derived cell populations can be directed to express disease-relevant genes and to display characteristics of the disease-specific cell type. These genetically manipulated hESC-derived motor neurons can facilitate and advance the study of disease-specific cellular pathways, and serve as a model system to test new therapeutic approaches.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available